Cost-effectiveness of allopurinol versus febuxostat in the treatment of gout patients: A systematic review

Background: In recent years, increased longevity, poor dietary habits, and the rising prevalence of metabolic syndrome and hypertension have increased the prevalence of gout. Gout significantly increases direct and indirect costs and reduces the quality of life. Allopurinol and febuxostat are the mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezapour, Aziz, Alidoost, Saeide, Asgharzadeh, Asra, Farhadi, Zeynab, Khodadadi, Najme, Mohammadi Bakhsh, Roghayeh, Sepehrian, Razieh, Salemi, Morteza, Taheri Mirghaed, Masood, Behzadifar, Masoud, Sohrabi, Rahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iran University of Medical Sciences 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456432/
https://www.ncbi.nlm.nih.gov/pubmed/32884916
http://dx.doi.org/10.34171/mjiri.34.41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456432/
https://www.ncbi.nlm.nih.gov/pubmed/32884916
http://dx.doi.org/10.34171/mjiri.34.41

Ejemplares similares